BHCM
PAHC icon

Brevan Howard Capital Management’s Phibro Animal Health PAHC Stock Holding History

Brevan Howard Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
23,365
+16,032
+219% +$676K 0.01% 1237
2026
Q1 		$406K Buy
+7,333
New +$349K ﹤0.01% 1429

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Brevan Howard Capital Management's PAHC Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Phibro Animal Health (PAHC) stake by 219% in Q2 2026, buying an estimated $676K and bringing the position to 23,365 shares worth $734K. The position accounts for 0.01% of the portfolio, ranked #1237.

Brevan Howard Capital Management first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Brevan Howard Capital Management held 23,365 shares of Phibro Animal Health worth $734K as of Q2 2026.
  • Brevan Howard Capital Management bought 16,032 Phibro Animal Health shares in Q2 2026, an estimated $676K.
  • Phibro Animal Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1237 holding.
  • Brevan Howard Capital Management first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.